1. Home
  2. XBIT vs RDI Comparison

XBIT vs RDI Comparison

Compare XBIT & RDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XBiotech Inc.

XBIT

XBiotech Inc.

N/A

Current Price

$1.95

Market Cap

57.6M

Sector

Health Care

ML Signal

N/A

Logo Reading International Inc

RDI

Reading International Inc

N/A

Current Price

$1.98

Market Cap

49.0M

ML Signal

N/A

Company Overview

Basic Information
Metric
XBIT
RDI
Founded
2005
1937
Country
United States
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Movies/Entertainment
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
57.6M
49.0M
IPO Year
2015
1994

Fundamental Metrics

Financial Performance
Metric
XBIT
RDI
Price
$1.95
$1.98
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 82.6K
22.2K
Earning Date
11-12-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 60.76
EPS
N/A
★ N/A
Revenue
N/A
★ $202,988,000.00
Revenue This Year
N/A
$15.10
Revenue Next Year
$30.47
$4.04
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.80
$0.94
52 Week High
$2.73
$2.41

Technical Indicators

Market Signals
Indicator
XBIT
RDI
Relative Strength Index (RSI) 45.36 65.07
Support Level $1.83 $1.64
Resistance Level $2.42 $2.13
Average True Range (ATR) 0.11 0.12
MACD 0.01 0.04
Stochastic Oscillator 45.45 96.34

Price Performance

Historical Comparison
XBIT
RDI

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

About RDI Reading International Inc

Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial and live theater assets.

Share on Social Networks: